Search

Your search keyword '"Liliana Vazquez Fernandez"' showing total 11 results
Start Over Author "Liliana Vazquez Fernandez"
11 results on '"Liliana Vazquez Fernandez"'

1. Heat-related cardiorespiratory mortality: Effect modification by air pollution across 482 cities from 24 countries

Author

Masna Rai, Massimo Stafoggia, Francesca de'Donato, Matteo Scortichini, Sofia Zafeiratou, Liliana Vazquez Fernandez, Siqi Zhang, Klea Katsouyanni, Evangelia Samoli, Shilpa Rao, Eric Lavigne, Yuming Guo, Haidong Kan, Samuel Osorio, Jan Kyselý, Aleš Urban, Hans Orru, Marek Maasikmets, Jouni J.K. Jaakkola, Niilo Ryti, Mathilde Pascal, Masahiro Hashizume, Chris Fook Sheng Ng, Barrak Alahmad, Magali Hurtado Diaz, César De la Cruz Valencia, Baltazar Nunes, Joana Madureira, Noah Scovronick, Rebecca M. Garland, Ho Kim, Whanhee Lee, Aurelio Tobias, Carmen Íñiguez, Bertil Forsberg, Christofer Åström, Ana Maria Vicedo-Cabrera, Martina S. Ragettli, Yue-Liang Leon Guo, Shih-Chun Pan, Shanshan Li, Antonio Gasparrini, Francesco Sera, Pierre Masselot, Joel Schwartz, Antonella Zanobetti, Michelle L. Bell, Alexandra Schneider, and Susanne Breitner

Subjects
Heat, Air temperature, Air pollution, Cardiovascular mortality, Respiratory mortality, Effect modification, Environmental sciences, GE1-350
Abstract

Background: Evidence on the potential interactive effects of heat and ambient air pollution on cause-specific mortality is inconclusive and limited to selected locations. Objectives: We investigated the effects of heat on cardiovascular and respiratory mortality and its modification by air pollution during summer months (six consecutive hottest months) in 482 locations across 24 countries. Methods: Location-specific daily death counts and exposure data (e.g., particulate matter with diameters ≤ 2.5 µm [PM2.5]) were obtained from 2000 to 2018. We used location-specific confounder-adjusted Quasi-Poisson regression with a tensor product between air temperature and the air pollutant. We extracted heat effects at low, medium, and high levels of pollutants, defined as the 5th, 50th, and 95th percentile of the location-specific pollutant concentrations. Country-specific and overall estimates were derived using a random-effects multilevel meta-analytical model. Results: Heat was associated with increased cardiorespiratory mortality. Moreover, the heat effects were modified by elevated levels of all air pollutants in most locations, with stronger effects for respiratory than cardiovascular mortality. For example, the percent increase in respiratory mortality per increase in the 2-day average summer temperature from the 75th to the 99th percentile was 7.7% (95% Confidence Interval [CI] 7.6–7.7), 11.3% (95%CI 11.2–11.3), and 14.3% (95% CI 14.1–14.5) at low, medium, and high levels of PM2.5, respectively. Similarly, cardiovascular mortality increased by 1.6 (95%CI 1.5–1.6), 5.1 (95%CI 5.1–5.2), and 8.7 (95%CI 8.7–8.8) at low, medium, and high levels of O3, respectively. Discussion: We observed considerable modification of the heat effects on cardiovascular and respiratory mortality by elevated levels of air pollutants. Therefore, mitigation measures following the new WHO Air Quality Guidelines are crucial to enhance better health and promote sustainable development.

Published
2023
Full Text
View/download PDF

2. Defining the Burden of Disease of RSV in Europe: estimates of RSV-associated hospitalisations in children under 5 years of age. A systematic review and modelling study

Author

Marco Del Riccio, Peter Spreeuwenberg, Richard Osei-Yeboah, Caroline K. Johannesen, Liliana Vazquez Fernandez, Anne C. Teirlinck, Xin Wang, Terho Heikkinen, Mathieu Bangert, Saverio Caini, Harry Campbell, and John Paget

Abstract

BackgroundRespiratory syncytial virus (RSV) infections cause an estimated 22-50 million episodes of acute lower respiratory infections (ALRI) every year in children younger than 5 years. To date, no overall estimate of RSV-associated hospitalisations in children under 5 years has been published for the European Union (EU). Through statistical modelling, we estimated the RSV hospitalisation burden in children under 5 years of age in EU countries and Norway, by age group and country.MethodsWe collated national RSV-associated hospitalisation estimates calculated using linear regression models in children under 5 years via the RESCEU project for Denmark, England, Finland, Norway, the Netherlands and Scotland during 2006-2018. A systematic literature review was conducted to collect additional estimates. Using the multiple imputation and nearest neighbour matching extrapolation methods, we estimated RSV-associated hospitalisation rates in all EU countries.ResultsAdditional estimates for Spain and France were found in the literature and added to the analysis. We estimated that an average of 245,244 (95%CI 224,688-265,799) hospital admissions with a respiratory infection per year were associated with RSV in children under the age of 5, with most cases occurring among children aged less than 1 year (75%). Infants aged less than 2 months represented the most affected group (71.6 per 1,000 children; 95%CI: 66.6-76.6). The hospitalisation rates varied widely across countries: for example, estimated rates in the 0-2 months age group ranged from 47.4 (37.5-57.3) per 1,000 in the Netherlands to 98.3 (88.5-108.1) per 1,000 in France.ConclusionTo our knowledge, this is the first attempt to estimate the overall RSV hospitalisation burden in children under the age of 5 years in the EU. Our findings will help support decisions regarding prevention efforts, and they will also represent an important benchmark to understand changes in the RSV burden following the introduction of RSV immunisation programs in Europe.

Published
2023

3. Effects of Air Temperature Modified by Vulnerability Factors

Author

Alexandra Schneider, Siqi Zhang, Masna Rai, Susanne Breitner, Massimo Stafoggia, Francesca De' Donato, Antonio Gasparrini, Pierre Masselot, Klea Katsouyanni, Evangelia Samoli, Antonis Analitis, Sofia Zafeiratou, Shilpa Rao, Liliana Vazquez Fernandez, and Stefan Agewall

Subjects
Europe, Respiratory diseases, Cardiovascular diseases, Vulnerability factors, Temperature, Air pollution, Climate change
Abstract

The report “Effects of Air Temperature Modified by Vulnerability Factors” was prepared as a milestone by researchers in the EU Project EXHAUSTION*. This report summarises the evidence on the interactive effects of high air temperature and various vulnerability factors, including the environmental, socio-economic, and individual behavioral factors on heart- and lung-related deaths and diseases (cardiopulmonary mortality and morbidity) across Europe. The study was conducted at the city, small-area (e.g., municipalities), and individual level. The findings show a greater vulnerability to heat for people living in urban areas with dense population, high air pollution levels, low coverage of green spaces, as well as areas with low Gross Domestic Product. Moreover, people with chronic pre-existing diseases and the elderly were found to be at greater risk. The findings highlight the urgent need to improve the urban environment as well as the health status and living conditions in European cities to contrast the impacts of heat and future climate change. This report alerts stakeholders and policymakers that targeted climate change adaptation measures need to be considered to protect vulnerable population and thereby increase European resilience to climate change.

Published
2022
Full Text
View/download PDF

4. Short-term heat effects and effect modification by ambient air pollution on cardiovascular and respiratory mortality across 148 cities from 13 European countries – Results of the EXHAUSTION project

Author

Masna Rai, Massimo Stafoggia, Francesca De'Donato, Antonio Gasparrini, Pierre Masselot, Envangelia Samoli, Sofia Zafeiratou, Klea Katsouyanni, Shilpa Rao, Liliana Vazquez Fernandez, Siqi Zhang, Kristin Aunan, Annette Peters, Alexandra Schneider, and Susanne Breitner

Subjects
General Earth and Planetary Sciences, General Environmental Science
Published
2022

5. Interactive effects of heat and air pollution on mortality in Europe using small area data – Results of the exhaustion project

Author

Francesca De Donato, Massimo Stafoggia, Susanne Breitner, Masna Rai, Siqi Zhang, Evangelia Samoli, Klea Katsouyanni, Sofia Zafeiratou, Antonio Gasparrini, Pierre Masselot, Liliana Vazquez-Fernandez, Alfonso Diz-Lois Palomares, Shilpa Rao, Kristin Aunan, and Alexandra Schneider

Subjects
General Earth and Planetary Sciences, General Environmental Science
Published
2022

6. Analysis of short-term heat effects on cardiopulmonary mortality using national and regional small area data – Results of the EXHAUSTION project

Author

Massimo Stafoggia, Susanne Breitner, Francesca de’ Donato, Alfonso Diz-Lois Palomares, Antonio Gasparrini, Pierre Masselot, Shilpa Rao, Evangelia Samoli, Liliana Vazquez Fernandez, Sofia Zafeiratou, Siqi Zhang, Kristin Aunan, and Alexandra Schneider

Subjects
General Earth and Planetary Sciences, General Environmental Science
Published
2022

8. Effects of Air Temperature on Cardiopulmonary Mortality and Morbidity in Europe

Author

Massimo Stafoggia, Alexandra Schneider, Masna Rai, Siqi Zhang, Susanne Breitner, Antonio Gasparrini, Pierre Masselot, Klea Katsouyanni, Evangelia Samoli, Antonis Analitis, Sofia Zafeiratou, Shilpa Rao, Liliana Vazquez Fernandez, Stefan Agewall, and Francesca De' Donato

Subjects
Europe, Temperature, Climate change, Cardiovascular disease, Respiratory disease
Abstract

The report “Effects of air Temperature on Cardiopulmonary Mortality and Morbidity in Europe” was prepared as a milestone of the EU Project EXHAUSTION. It summarizes the evidence on the effects of different levels and changes in ambient air temperature on cardiopulmonary (CPD) mortality and morbidity across Europe and puts a spotlight on the vulnerable and susceptible population. It can help stakeholders and policymakers to plan adaptation measures to protect the vulnerable and susceptible population and increase European resilience towards climate change and extreme weather events.

Published
2021
Full Text
View/download PDF

9. The burden of hospital-attended influenza in Norwegian children

Author

Håkon Bøås, Terese Bekkevold, Lise Beier Havdal, Anne-Marte Bakken Kran, Astrid Elisabeth Rojahn, Ketil Størdal, Sara Debes, Henrik Døllner, Svein Arne Nordbø, Bjørn Barstad, Elisebet Haarr, Liliana Vázquez Fernández, Britt Nakstad, Truls Michael Leegaard, Olav Hungnes, Elmira Flem, Norwegian Enhanced Pediatric Immunisation Surveillance (NorEPIS) Network, and Christopher Inchley

Subjects
hospital-attended influenza, pediatric, children, surveillance, disease burden, Pediatrics, RJ1-570
Abstract

BackgroundNorwegian health authorities do not recommend universal pediatric vaccination against seasonal influenza. We aimed to estimate the incidence of influenza by age and underlying medical conditions in hospitalized Norwegian children aged

Published
2022
Full Text
View/download PDF

10. Risk factors associated with severe disease in respiratory syncytial virus infected children under 5 years of age

Author

Lise Beier Havdal, Håkon Bøås, Terese Bekkevold, Anne-Marte Bakken Kran, Astrid Elisabeth Rojahn, Ketil Størdal, Sara Debes, Henrik Døllner, Svein Arne Nordbø, Bjørn Barstad, Elisebet Haarr, Liliana Vázquez Fernández, Britt Nakstad, Christopher Inchley, and Elmira Flem

Subjects
respiratory syncytial virus (RSV), risk factor (RF), disease severity analysis, pediatric infection, respiratory infection, Pediatrics, RJ1-570
Abstract

ObjectiveTo evaluate risk factors for severe disease in children under 59 months of age hospitalized with respiratory syncytial virus (RSV) infection.Study designWe prospectively enrolled 1,096 cases of laboratory confirmed RSV infection during three consecutive RSV seasons in 2015–2018. Potential risk factors for severe disease were retrieved through patient questionnaires and linkage to national health registries. Need for respiratory support (invasive ventilation, bi-level positive airway pressure, or continuous positive airway pressure), and length of stay exceeding 72 h were used as measures of disease severity. Associations were investigated using multivariable logistic regression analyses. Multiple imputation was used to avoid bias and inference induced by missing data.ResultsRisk factors associated with a need for respiratory support included age younger than 3 months of age [aOR: 6.73 (95% CI 2.71–16.7)], having siblings [aOR: 1.65 (95% CI 1.05–2.59)] and comorbidity [aOR: 2.40 (95% CI 1.35–4.24)]. The length of hospital stay >72 h was significantly associated with being younger than 3 months of age [aOR: 3.52 (95% CI 1.65–7.54)], having siblings [aOR: 1.45 (95% CI 1.01–2.08)], and comorbidity [aOR: 2.18 (95% CI 1.31–3.61)]. Sub-group analysis of children younger than 6 months of age confirmed the association between both young age and having siblings and the need for respiratory support.ConclusionIn a large cohort of children

Published
2022
Full Text
View/download PDF

11. Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018

Author

Merdrignac, Lore, Aït El Belghiti, Fatima, Pandolfi, Elisabetta, Jané, Mireia, Murphy, Jane, Fabiánová, Kateřina, García Cenoz, Manuel, Flem, Elmira, Guillot, Sophie, Tozzi, Alberto E, Carmona, Gloria, Habington, Adele, Zavadilová, Jana, Navasués, Ana, Bøås, Håkon, Lévy-Brühl, Daniel, Ferretti, Beatrice, Lanaspa, Miguel, O’Sullivan, Niam, Křížová, Pavla, Fernandino, Leticia, Bekkevold, Terese, Hanslik, Thomas, Muñoz-Almagro, Carmen, Bacci, Sabrina, Spiteri, Gianfranco, Valenciano, Marta, Moren, Alain, Savulescu, Camelia, Blechová, Zuzana, Bláhová, Květa, Kosina, Pavel, Sýkora, Josef, Holčíková, Alena, Širůček, Petr, Grembombo, Adèle, Brisse, Sylvain, Toubiana, Julie, Cotter, Suzanne, Cunney, Robert, O’Shaughnessy, Norma, O’Sullivan, Niamh, Rizzo, Caterina, Russo, Luisa, Campagna, Ilaria, Gesualdo, Francesco, Ciampini, Sara, Annarosa Ferro, Valentina, Boccuzzi, Elena, Vazquez Fernandez, Liliana, Esteva, Cristina, Lanaspa Perez, Miguel, Acosta, Lesly, Jordan Garcia, Yolanda, Navascués, Ana, Fernandino Zubieta, Leticia, Castilla, Jesús, EpiConcept [Paris], Direction des maladies infectieuses - Infectious Diseases Division [Saint-Maurice], Santé publique France - French National Public Health Agency [Saint-Maurice, France], IRCCS Ospedale Pediatrico Bambino Gesù [Roma], Public Health Agency of Catalonia [Barcelona, Spain] (PHAC), Temple Street Children's University Hospital [Dublin], National Institute of Public Health [Prague], Instituto de Investigación Sanitaria de Navarra [Pamplona, Spain] (IdiSNA), Norwegian Institute of Public Health [Oslo] (NIPH), Biodiversité et Epidémiologie des Bactéries pathogènes - Biodiversity and Epidemiology of Bacterial Pathogens, Institut Pasteur [Paris] (IP), Our Lady's Children's Hospital Crumlin (OLCHC), Complejo Hospitalario de Navarra, Institut de Recerca Pediàtrica Hospital Sant Joan de Déu [Barcelona, Spain], Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Universitat Internacional de Catalunya, CIBER de Epidemiología y Salud Pública (CIBERESP), European Centre for Disease Prevention and Control [Stockholm, Sweden] (ECDC), The European Centre for Disease Prevention and Control (ECDC) funded the PERTINENT study (Framework contract n° ECDC/2015/017)., PERTINENT group : Epiconcept, France: Lore Merdrignac, Epiconcept, Camelia Savulescu, Epiconcept, Marta Valenciano, Epiconcept, Alain Moren, Epiconcept. Czech Republic: Pavla Křížová, National Institute of Public Health, Prague, Kateřina Fabiánová, National Institute of Public Health, Prague, Jana Zavadilová, National Institute of Public Health, Prague, Zuzana Blechová, University Hospital Na Bulovce, Prague, Květa Bláhová, University Hospital Motol, Prague, Pavel Kosina, University Hospital, Hradec Králové, Josef Sýkora, University Hospital, Pilsen, Alena Holčíková, University Hospital, Brno, Petr Širůček, University Hospital, Ostrava. France: Daniel Lévy-Brühl, Santé Publique France, Saint-Maurice, Fatima Aït El Belghiti, Santé Publique France, Saint-Maurice, Adèle Grembombo, Santé Publique France, Saint-Maurice, Sophie Guillot, Institut Pasteur, Paris, Sylvain Brisse, Institut Pasteur, Paris, Julie Toubiana, Institut Pasteur, Paris. Ireland: Suzanne Cotter, HSE-Health Protection Surveillance Centre, Dublin, Jane Murphy, Temple Street Children’s University Hospital, Dublin, Robert Cunney, Temple Street Children’s University Hospital, Dublin, Norma O’Shaughnessy, Temple Street Children’s University Hospital, Dublin, Adele Habington, Our Lady’s Children’s hospital Crumlin, Dublin, Niamh O’Sullivan, Our Lady’s Children’s hospital Crumlin, Dublin. Italy: Elisabetta Pandolfi, Bambino Gesù Children Hospital, Rome, Alberto E Tozzi, Bambino Gesù Children Hospital, Rome, Caterina Rizzo, Bambino Gesù Children Hospital, Rome, Luisa Russo, Bambino Gesù Children Hospital, Rome, Ilaria Campagna, Bambino Gesù Children Hospital, Rome, Francesco Gesualdo, Bambino Gesù Children Hospital, Rome, Sara Ciampini, Bambino Gesù Children Hospital, Rome, Valentina Annarosa Ferro, Bambino Gesù Children Hospital, Rome, Elena Boccuzzi, Bambino Gesù Children Hospital, Rome. Norway: Elmira Flem, Norwegian Institute of Public Health, Oslo, Håkon Bøås, Norwegian Institute of Public Health, Oslo, Terese Bekkevold, Norwegian Institute of Public Health, Oslo, Liliana Vazquez Fernandez, Norwegian Institute of Public Health, Oslo. Catalonia, Spain: Carmen Muñoz-Almagro, Instituto de Recerca Pediatrica Hospital Sant Joan de Deu, Barcelona, Universitat Internacional de Catalunya and CIBER of Epidemiology and Public Health CIBERESP, Cristina Esteva, Instituto de Recerca Pediatrica Hospital Sant Joan de Deu, Barcelona, CIBER of Epidemiology and Public Health CIBERESP, Miguel Lanaspa Perez, Instituto de Recerca Pediatrica Hospital Sant Joan de Deu, Barcelona, Mireia Jané, Public Health Agency of Catalonia, Barcelona, University of Barcelona, Gloria Carmona, Public Health Agency of Catalonia, Barcelona, Lesly Acosta, Universitat Politècnica de Catalunya - BarcelonaTech (UPC), Public Health Agency of Catalonia, Barcelona, Yolanda Jordan Garcia, Instituto de Recerca Pediatrica Hospital Sant Joan de Deu, Barcelona, CIBER of Epidemiology and Public Health CIBERESP. Navarra, Spain: Manuel García Cenoz, Instituto de Salud Pública de Navarra, IdiSNA – Navarre Institute for Health Research, Pamplona, Ana Navascués, Complejo Hospitalario de Navarra, Pamplona, Leticia Fernandino Zubieta, Instituto de Salud Pública de Navarra, IdiSNA – Navarre Institute for Health Research, Pamplona, Jesús Castilla, Instituto de Salud Pública de Navarra, IdiSNA - Navarre Institute for Health Research, Pamplona. Sentinelles, France: Thomas Hanslik, Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris. ECDC: Sabrina Bacci, European Centre for Disease Prevention and Control, Stockholm, Sweden, Gianfranco Spiteri, European Centre for Disease Prevention and Control, Stockholm, Sweden., Universitat Politècnica de Catalunya. Departament d'Estadística i Investigació Operativa, Universitat Politècnica de Catalunya. ADBD - Anàlisi de Dades Complexes per a les Decisions Empresarials, Brisse, Sylvain, European Centre for Disease Prevention and Control (ECDC), and Institut Pasteur [Paris]

Subjects
Male, 0301 basic medicine, Bordetella pertussis, Pediatrics, Whooping Cough, Epidemiology, Infants -- Salut i Higiene, Hospitals - Admission and discharge, Children -- Health and hygiene, Infants (Newborn), 0302 clinical medicine, Interquartile range, pertussis incidence, 030212 general & internal medicine, Vacunació, Czech Republic, media_common, Pertussis Vaccine, Babies, Surveillance, biology, Norway, Incidence, Incidence (epidemiology), pertussis, Vaccination, Gestational age, Hospitals -- Ingressos i altes, Hospitals, 3. Good health, Europe, Hospitalization, Italy, Nodrissons, hospital surveillance, France, Niños -- Salud e higiene, medicine.medical_specialty, 030106 microbiology, Hospitales -- Admisión y alta, 03 medical and health sciences, Virology, Intensive care, medicine, Humans, media_common.cataloged_instance, Tos ferina, European Union, European union, Disease burden, Aged, Whooping cough, business.industry, Infants nadons -- Malalties, active surveillance, Infant, Newborn, Public Health, Environmental and Occupational Health, Vacunación, Infant, biology.organism_classification, Tosferina, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Lactantes, business, Ireland, Ciències de la salut [Àrees temàtiques de la UPC]
Abstract

Introduction PERTINENT is a pilot active surveillance system of infants hospitalised with pertussis in six European Union/European Economic Area countries (37 hospitals, seven sites). Aim This observational study aimed to estimate annual pertussis incidence per site from 2016 to 2018 and respective trends between 2017 and 2018. Pertussis cases were described, including their severity. Methods We developed a generic protocol and laboratory guidelines to harmonise practices across sites. Cases were hospitalised infants testing positive for Bordetella pertussis by PCR or culture. Sites collected demographic, clinical, laboratory data, vaccination status, and risk/protective factors. We estimated sites’ annual incidences by dividing case numbers by the catchment populations. Results From December 2015 to December 2018, we identified 469 cases (247 males; 53%). The median age, birthweight and gestational age were 2.5 months (range: 0–11.6; interquartile range (IQR): 2.5), 3,280 g (range: 700–4,925; IQR: 720) and 39 weeks (range: 25–42; IQR: 2), respectively. Thirty cases (6%) had atypical presentation either with cough or cyanosis only or with absence of pertussis-like symptoms. Of 330 cases with information, 83 (25%) were admitted to intensive care units including five deceased infants too young to be vaccinated. Incidence rate ratios between 2018 and 2017 were 1.43 in Czech Republic (p = 0.468), 0.25 in Catalonia (p = 0.002), 0.71 in France (p = 0.034), 0.14 in Ireland (p = 0.002), 0.63 in Italy (p = 0.053), 0.21 in Navarra (p = 0.148) and zero in Norway. Conclusions Incidence appeared to decrease between 2017 and 2018 in all but one site. Enhanced surveillance of hospitalised pertussis in Europe is essential to monitor pertussis epidemiology and disease burden.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results